1-3 of 3
Jingxia Li
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Role of STAT3 and FOXO1 in the Divergent Therapeutic Responses of Non-metastatic and Metastatic Bladder Cancer Cells to miR-145

Free
Guosong Jiang, Chao Huang, Jingxia Li, Haishan Huang, Honglei Jin, Junlan Zhu, Xue-Ru Wu, Chuanshu Huang
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (5): 924–935.
https://doi.org/10.1158/1535-7163.MCT-16-0631
Published: 02 May 2017
View articletitled, Role of STAT3 and FOXO1 in the Divergent Therapeutic Responses of Non-metastatic and Metastatic Bladder Cancer Cells to miR-145
Open the PDF for Role of STAT3 and FOXO1 in the Divergent Therapeutic Responses of Non-metastatic and Metastatic Bladder Cancer Cells to miR-145 in another window
Journal Articles

Induction of miR-137 by Isorhapontigenin (ISO) Directly Targets Sp1 Protein Translation and Mediates Its Anticancer Activity Both In Vitro and In Vivo

Free
Xingruo Zeng, Zhou Xu, Jiayan Gu, Haishan Huang, Guangxun Gao, Xiaoru Zhang, Jingxia Li, Honglei Jin, Guosong Jiang, Hong Sun, Chuanshu Huang
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2016) 15 (3): 512–522.
https://doi.org/10.1158/1535-7163.MCT-15-0606
Published: 06 March 2016
View articletitled, Induction of miR-137 by Isorhapontigenin (ISO) Directly Targets Sp1 Protein Translation and Mediates Its Anticancer Activity Both In Vitro and In Vivo
Open the PDF for Induction of miR-137 by Isorhapontigenin (ISO) Directly Targets Sp1 Protein Translation and Mediates Its Anticancer Activity Both In Vitro and In Vivo in another window
Journal Articles

Cyclin D1 Downregulation Contributes to Anticancer Effect of Isorhapontigenin on Human Bladder Cancer Cells

Free
Yong Fang, Zipeng Cao, Qi Hou, Chen Ma, Chunsuo Yao, Jingxia Li, Xue-Ru Wu, Chuanshu Huang
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (8): 1492–1503.
https://doi.org/10.1158/1535-7163.MCT-12-0922
Published: 08 August 2013
View articletitled, Cyclin D1 Downregulation Contributes to Anticancer Effect of Isorhapontigenin on Human Bladder Cancer Cells
Open the PDF for Cyclin D1 Downregulation Contributes to Anticancer Effect of Isorhapontigenin on Human Bladder Cancer Cells in another window